PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'DKMS, Tübingen, Germany.\', \'DKMS, Clinical Trials Unit, Dresden, Germany.\', \'DKMS, Clinical Trials Unit, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.\', \'DKMS Life Science Lab, Dresden, Germany.\', \'DKMS, Tübingen, Germany; DKMS, Clinical Trials Unit, Dresden, Germany; DKMS Life Science Lab, Dresden, Germany.\', \'DKMS, Clinical Trials Unit, Dresden, Germany; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany. Electronic address: schetelig@dkms.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00195-810.1016/j.ijid.2021.02.108
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33667698
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • CCR5Δ32 mutations do not determine COVID-19 disease course.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all